-
1
-
-
81855206806
-
Screening for prostate cancer: A review of the evidence for the US Preventive Services Task Force
-
Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2011;155(11):762-771.
-
(2011)
Ann Intern Med
, vol.155
, Issue.11
, pp. 762-771
-
-
Chou, R.1
Croswell, J.M.2
Dana, T.3
-
2
-
-
84872335815
-
-
Accessed December 2, 2011
-
US Preventive Services Task Force. Grade definitions. http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm. Accessed December 2, 2011.
-
Grade Definitions
-
-
-
3
-
-
63249118690
-
ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study
-
Schröder FH, Hugosson J, Roobol MJ, et al. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320-1328.
-
(2009)
N Engl J Med
, vol.360
, Issue.13
, pp. 1320-1328
-
-
Schröder, F.H.1
Hugosson, J.2
Roobol, M.J.3
-
4
-
-
63249122661
-
Mortality results from a randomized prostate-cancer screening trial
-
PLCO Project Team
-
Andriole GL, Crawford ED, Grubb RL III, et al. PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310-1319.
-
(2009)
N Engl J Med
, vol.360
, Issue.13
, pp. 1310-1319
-
-
Andriole, G.L.1
Crawford, E.D.2
Grubb III, R.L.3
-
5
-
-
77955279420
-
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
-
Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 2010;11(8):725-732.
-
(2010)
Lancet Oncol
, vol.11
, Issue.8
, pp. 725-732
-
-
Hugosson, J.1
Carlsson, S.2
Aus, G.3
-
6
-
-
2442681667
-
Prostate cancer incidence and mortality rates and trends in the United States and Canada
-
McDavid K, Lee J, Fulton JP, Tonita J, Thompson TD. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep. 2004;119(2):174-186. (Pubitemid 38661087)
-
(2004)
Public Health Reports
, vol.119
, Issue.2
, pp. 174-186
-
-
McDavid, K.1
Lee, J.2
Fulton, J.P.3
Tonita, J.4
Thompson, T.D.5
-
7
-
-
56749163379
-
Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: Fifteen-year follow-up
-
Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery E, Barry MJ. Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up. J Gen Intern Med. 2008;23(11):1809-1814.
-
(2008)
J Gen Intern Med
, vol.23
, Issue.11
, pp. 1809-1814
-
-
Lu-Yao, G.1
Albertsen, P.C.2
Stanford, J.L.3
Stukel, T.A.4
Walker-Corkery, E.5
Barry, M.J.6
-
8
-
-
77949898163
-
Time trends and local variation in primary treatment of localized prostate cancer
-
Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117-1123.
-
(2010)
J Clin Oncol
, vol.28
, Issue.7
, pp. 1117-1123
-
-
Cooperberg, M.R.1
Broering, J.M.2
Carroll, P.R.3
-
9
-
-
0031203890
-
The Prostate Cancer Intervention Versus Observation Trial (PIVOT)
-
Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial (PIVOT). Oncology (Williston Park). 1997;11(8):1133-1139. (Pubitemid 127637991)
-
(1997)
ONCOLOGY
, vol.11
, Issue.8
, pp. 1133-1139
-
-
Wilt, T.J.1
Brawer, M.K.2
Barnhill, J.3
Barry, M.4
Blumenstein, B.5
Collins, J.6
Crowley, A.7
Culkin, D.8
Fox, S.9
Johnson, C.10
Kaplan, R.11
Moon, T.12
Scardino, P.13
Thompson, I.14
Weiss, D.15
Wheeler, T.16
|